239 related articles for article (PubMed ID: 26435478)
1. Apigenin blocks IKKα activation and suppresses prostate cancer progression.
Shukla S; Kanwal R; Shankar E; Datt M; Chance MR; Fu P; MacLennan GT; Gupta S
Oncotarget; 2015 Oct; 6(31):31216-32. PubMed ID: 26435478
[TBL] [Abstract][Full Text] [Related]
2. Suppression of NF-κB and NF-κB-Regulated Gene Expression by Apigenin through IκBα and IKK Pathway in TRAMP Mice.
Shukla S; Shankar E; Fu P; MacLennan GT; Gupta S
PLoS One; 2015; 10(9):e0138710. PubMed ID: 26379052
[TBL] [Abstract][Full Text] [Related]
3. Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway.
Shukla S; Bhaskaran N; Babcook MA; Fu P; Maclennan GT; Gupta S
Carcinogenesis; 2014 Feb; 35(2):452-60. PubMed ID: 24067903
[TBL] [Abstract][Full Text] [Related]
4. Apigenin suppresses insulin-like growth factor I receptor signaling in human prostate cancer: an in vitro and in vivo study.
Shukla S; Gupta S
Mol Carcinog; 2009 Mar; 48(3):243-252. PubMed ID: 18726972
[TBL] [Abstract][Full Text] [Related]
5. Effects of IKK inhibitor PS1145 on NF-kappaB function, proliferation, apoptosis and invasion activity in prostate carcinoma cells.
Yemelyanov A; Gasparian A; Lindholm P; Dang L; Pierce JW; Kisseljov F; Karseladze A; Budunova I
Oncogene; 2006 Jan; 25(3):387-98. PubMed ID: 16170348
[TBL] [Abstract][Full Text] [Related]
6. The chemopreventive bioflavonoid apigenin inhibits prostate cancer cell motility through the focal adhesion kinase/Src signaling mechanism.
Franzen CA; Amargo E; Todorović V; Desai BV; Huda S; Mirzoeva S; Chiu K; Grzybowski BA; Chew TL; Green KJ; Pelling JC
Cancer Prev Res (Phila); 2009 Sep; 2(9):830-41. PubMed ID: 19737984
[TBL] [Abstract][Full Text] [Related]
7. Lycopene acts through inhibition of IκB kinase to suppress NF-κB signaling in human prostate and breast cancer cells.
Assar EA; Vidalle MC; Chopra M; Hafizi S
Tumour Biol; 2016 Jul; 37(7):9375-85. PubMed ID: 26779636
[TBL] [Abstract][Full Text] [Related]
8. The Novel IκB Kinase β Inhibitor, IMD-0560, Has Potent Therapeutic Efficacy in Ovarian Cancer Xenograft Model Mice.
Sawada I; Hashimoto K; Sawada K; Kinose Y; Nakamura K; Toda A; Nakatsuka E; Yoshimura A; Mabuchi S; Fujikawa T; Itai A; Kimura T
Int J Gynecol Cancer; 2016 May; 26(4):610-8. PubMed ID: 26905334
[TBL] [Abstract][Full Text] [Related]
9. Carnosic acid modulates Akt/IKK/NF-κB signaling by PP2A and induces intrinsic and extrinsic pathway mediated apoptosis in human prostate carcinoma PC-3 cells.
Kar S; Palit S; Ball WB; Das PK
Apoptosis; 2012 Jul; 17(7):735-47. PubMed ID: 22453599
[TBL] [Abstract][Full Text] [Related]
10. The natural flavonoid apigenin sensitizes human CD44
Erdogan S; Turkekul K; Serttas R; Erdogan Z
Biomed Pharmacother; 2017 Apr; 88():210-217. PubMed ID: 28107698
[TBL] [Abstract][Full Text] [Related]
11. Involvement of nuclear factor-kappa B, Bax and Bcl-2 in induction of cell cycle arrest and apoptosis by apigenin in human prostate carcinoma cells.
Gupta S; Afaq F; Mukhtar H
Oncogene; 2002 May; 21(23):3727-38. PubMed ID: 12032841
[TBL] [Abstract][Full Text] [Related]
12. IKK inhibitor suppresses epithelial-mesenchymal transition and induces cell death in prostate cancer.
Ping H; Yang F; Wang M; Niu Y; Xing N
Oncol Rep; 2016 Sep; 36(3):1658-64. PubMed ID: 27432067
[TBL] [Abstract][Full Text] [Related]
13. Apigenin inhibits TGF-β-induced VEGF expression in human prostate carcinoma cells via a Smad2/3- and Src-dependent mechanism.
Mirzoeva S; Franzen CA; Pelling JC
Mol Carcinog; 2014 Aug; 53(8):598-609. PubMed ID: 23359392
[TBL] [Abstract][Full Text] [Related]
14. Molecular mechanisms for apigenin-induced cell-cycle arrest and apoptosis of hormone refractory human prostate carcinoma DU145 cells.
Shukla S; Gupta S
Mol Carcinog; 2004 Feb; 39(2):114-26. PubMed ID: 14750216
[TBL] [Abstract][Full Text] [Related]
15. Japonicone A suppresses growth of Burkitt lymphoma cells through its effect on NF-κB.
Li X; Yang X; Liu Y; Gong N; Yao W; Chen P; Qin J; Jin H; Li J; Chu R; Shan L; Zhang R; Zhang W; Wang H
Clin Cancer Res; 2013 Jun; 19(11):2917-28. PubMed ID: 23620411
[TBL] [Abstract][Full Text] [Related]
16. Apigenin potentiates the growth inhibitory effects by IKK-β-mediated NF-κB activation in pancreatic cancer cells.
Wu DG; Yu P; Li JW; Jiang P; Sun J; Wang HZ; Zhang LD; Wen MB; Bie P
Toxicol Lett; 2014 Jan; 224(1):157-64. PubMed ID: 24148603
[TBL] [Abstract][Full Text] [Related]
17. Combined targeting of Arf1 and Ras potentiates anticancer activity for prostate cancer therapeutics.
Lang L; Shay C; Zhao X; Teng Y
J Exp Clin Cancer Res; 2017 Aug; 36(1):112. PubMed ID: 28830537
[TBL] [Abstract][Full Text] [Related]
18. Apigenin attenuates insulin-like growth factor-I signaling in an autochthonous mouse prostate cancer model.
Shukla S; MacLennan GT; Fu P; Gupta S
Pharm Res; 2012 Jun; 29(6):1506-17. PubMed ID: 22139534
[TBL] [Abstract][Full Text] [Related]
19. Blocking IKKα expression inhibits prostate cancer invasiveness.
Mahato R; Qin B; Cheng K
Pharm Res; 2011 Jun; 28(6):1357-69. PubMed ID: 21191633
[TBL] [Abstract][Full Text] [Related]
20. Expression of NF-κB-related proteins and their modulation during TNF-α-provoked apoptosis in prostate cancer cells.
Rodríguez-Berriguete G; Fraile B; Paniagua R; Aller P; Royuela M
Prostate; 2012 Jan; 72(1):40-50. PubMed ID: 21520161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
